sub field
BiotechDrug DiscoveryLongevity
stage
Startup
About
Jens Eckstein is a biotech venture investor and operator focused on healthy aging, translational science, and company creation. Public sources show him as an Investment Partner at Hevolution Foundation, a board director at Vandria SA, and an advisor to Apollo Health Ventures, where he previously served as Managing Partner. Earlier, he led SR One, GSK's corporate venture arm, and has been associated with company creation, board work, and early-stage biotech investing for more than two decades.
Areas of interest
drug discoverygerosciencebiotech venture capitalbiotechbiopharmaaging biologybiopharma company creationcompany creationhealthy lifespan interventionsbiopharma venture capitallife scienceshealthspanventure capitalklotho biologyhealthspan extensionlongevity